Bright Minds Biosciences Stock Analysis
| DRUG Stock | USD 35.57 0.42 1.17% |
Bright Minds Biosciences is overvalued with Real Value of 18.03 and Hype Value of 36.21. The main objective of Bright Minds stock analysis is to determine its intrinsic value, which is an estimate of what Bright Minds Biosciences is worth, separate from its market price. There are two main types of Bright Minds' stock analysis: fundamental analysis and technical analysis.
The Bright Minds stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Bright Minds' ongoing operational relationships across important fundamental and technical indicators.
Bright |
Bright Stock Analysis Notes
About 27.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.45. Bright Minds Biosciences had not issued any dividends in recent years. The entity had 1:5 split on the 14th of July 2023. Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT medicines to improve the lives of patients with severe and life-altering diseases. The company was incorporated in 2019 and is headquartered in Vancouver, Canada. Bright Minds is traded on NASDAQ Exchange in the United States. To learn more about Bright Minds Biosciences call Ian McDonald at 647 865 8622 or check out https://brightmindsbio.com.Bright Minds Biosciences Investment Alerts
| Bright Minds generated a negative expected return over the last 90 days | |
| Bright Minds has high historical volatility and very poor performance | |
| Bright Minds has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (2.8 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bright Minds Biosciences currently holds about 8.64 M in cash with (1.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.71. | |
| Bright Minds has a poor financial position based on the latest SEC disclosures | |
| Roughly 27.0% of the company shares are held by company insiders |
Bright Minds Biosciences Upcoming and Recent Events
| 6th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Bright Minds Thematic Classifications
In addition to having Bright Minds stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Pharmaceutical ProductsUSA Equities from Pharmaceutical Products industry as classified by Fama & French |
Bright Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 226.37 M.Technical Drivers
As of the 27th of March, Bright Minds shows the Risk Adjusted Performance of 0.0197, downside deviation of 3.86, and Mean Deviation of 3.41. Bright Minds Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Bright Minds Biosciences information ratio, as well as the relationship between the potential upside and kurtosis to decide if Bright Minds Biosciences is priced correctly, providing market reflects its regular price of 35.57 per share. Given that Bright Minds has jensen alpha of 0.0588, we suggest you to validate Bright Minds Biosciences's prevailing market performance to make sure the company can sustain itself at a future point.Bright Minds Biosciences Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Bright Minds middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Bright Minds Biosciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Bright Minds Biosciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bright Minds insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bright Minds' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Bright Minds insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cormorant Asset Management, Lp over three months ago Acquisition by Cormorant Asset Management, Lp of 184331 shares of Bright Minds at 21.7 subject to Rule 16b-3 | ||
Cormorant Asset Management, Lp over three months ago Insider Trading |
Bright Minds Outstanding Bonds
Bright Minds issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bright Minds Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bright bonds can be classified according to their maturity, which is the date when Bright Minds Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Bright Minds Predictive Daily Indicators
Bright Minds intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bright Minds stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 3377.95 | |||
| Daily Balance Of Power | (0.18) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 36.74 | |||
| Day Typical Price | 36.35 | |||
| Price Action Indicator | (1.37) | |||
| Period Momentum Indicator | (0.42) | |||
| Relative Strength Index | 50.04 |
Bright Minds Forecast Models
Bright Minds' time-series forecasting models are one of many Bright Minds' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bright Minds' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Bright Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Bright Minds prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bright shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bright Minds. By using and applying Bright Stock analysis, traders can create a robust methodology for identifying Bright entry and exit points for their positions.
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT medicines to improve the lives of patients with severe and life-altering diseases. The company was incorporated in 2019 and is headquartered in Vancouver, Canada. Bright Minds is traded on NASDAQ Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Bright Minds to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
| All Next | Launch Module |
Complementary Tools for Bright Stock analysis
When running Bright Minds' price analysis, check to measure Bright Minds' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bright Minds is operating at the current time. Most of Bright Minds' value examination focuses on studying past and present price action to predict the probability of Bright Minds' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bright Minds' price. Additionally, you may evaluate how the addition of Bright Minds to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |